TapewireFind a company

person · Reporting owner

Stevens Raymond C

Disclosed activity across 2 companies

Tapewire entity
14371
SEC CIK
0001698149

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
DANAHER CORP /DE/DHR · Entity 2871DirectorJuly 31, 2026August 04, 2026
Structure Therapeutics Inc.GPCR · Entity 1222Director · CHIEF EXECUTIVE OFFICERMarch 19, 2026March 23, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

DANAHER CORP /DE/

Report date July 31, 2026 · Filed August 04, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Phantom sharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct7,427.835 Reported balance After 2026-07-31 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-07-31 · Grant · Acquired 181.549 · Balance 7,427.835

F1: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees they are entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3: The reporting person is fully vested in all amounts deferred under the Plan.

Filing footnotes · ownership attribution and instrument terms

F1: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees they are entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3: The reporting person is fully vested in all amounts deferred under the Plan.

Structure Therapeutics Inc.

Report date March 19, 2026 · Filed March 23, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Ordinary SharesSEC Table I · non-derivativeDirect1,401,593 Reported balance After 2026-03-19 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-03-19 · Grant · Acquired 260,217 · Balance 1,401,593

F1: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

F2: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2026, subject to Reporting Person's continued service on such dates.

Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.82 · Expires 2036-03-18Direct322,230 Reported balance After 2026-03-19 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-03-19 · Grant · Acquired 322,230 · Balance 322,230

F4: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.

F5: 1/4th of the shares subject to the option shall vest March 1, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.

F1: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

Ordinary SharesSEC Table I · non-derivativeIndirectSee footnote1,554,586 Reported balance Holding disclosure · report date 2026-03-19 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 1,554,586

F1: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

F3: By Raymond Stevens and Vivian Urena-Stevens, as Co-Trustees of the Stevens 2001 Revocable Trust, dated March 28, 2001.

Filing footnotes · ownership attribution and instrument terms

F1: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

F2: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2026, subject to Reporting Person's continued service on such dates.

F3: By Raymond Stevens and Vivian Urena-Stevens, as Co-Trustees of the Stevens 2001 Revocable Trust, dated March 28, 2001.

F4: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.

F5: 1/4th of the shares subject to the option shall vest March 1, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
July 31, 2026 Filed Aug 4, 2026 21:00 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 181.549 $194.98 Strike: $0.00 $35,398.42
Disclosure

SEC source: 0000313616-26-000165 · wk-form4_1785877231.xml · derivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,427.835

Underlying: Common Stock · 181.549 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees they are entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

Read SEC document
May 15, 2026 Filed May 19, 2026 21:09 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantDirector stock option (right to buy) · Derivative 1,699 $0.00 Strike: $161.91 $0.00
Disclosure

SEC source: 0000313616-26-000145 · wk-form4_1779224996.xml · derivative · entry 2

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,699

Underlying: Common Stock · 1,699 shares

Expires 2036-05-15

Read SEC document
May 15, 2026 Filed May 19, 2026 21:09 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantCommon Stock 680 $0.00 $0.00
Disclosure

SEC source: 0000313616-26-000145 · wk-form4_1779224996.xml · nonDerivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,728.286

F1 · shares: On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board.

Read SEC document
April 24, 2026 Filed Apr 28, 2026 21:01 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 199.26 $177.25 Strike: $0.00 $35,318.84
Disclosure

SEC source: 0000313616-26-000123 · wk-form4_1777410066.xml · derivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,246.286

Underlying: Common Stock · 199.26 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
March 19, 2026 Filed Mar 23, 2026 20:30 UTC Structure Therapeutics Inc. GPCR · Entity 1222 GrantEmployee Stock Option (right to buy) · Derivative 322,230 $0.00 Strike: $16.82 $0.00
Disclosure

SEC source: 0001698149-26-000003 · form4-03232026_040301.xml · derivative · entry 3

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 322,230

Underlying: Ordinary Shares · 322,230 shares

Expires 2036-03-18

F4 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.

F5 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.

F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
March 19, 2026 Filed Mar 23, 2026 20:30 UTC Structure Therapeutics Inc. GPCR · Entity 1222 GrantOrdinary Shares 260,217 $0.00 $0.00
Disclosure

SEC source: 0001698149-26-000003 · form4-03232026_040301.xml · nonDerivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,401,593

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

F2 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2026, subject to Reporting Person's continued service on such dates.

Read SEC document
March 03, 2026 Filed Mar 5, 2026 23:20 UTC Structure Therapeutics Inc. GPCR · Entity 1222 Tax withholdingOrdinary Shares 53,454 $20.99 $1,121,999.46
Disclosure

SEC source: 0001698149-26-000002 · form4-03052026_060301.xml · nonDerivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,141,376

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

F2 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.

Read SEC document
January 30, 2026 Filed Feb 3, 2026 22:25 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 158.547 $218.89 Strike: $0.00 $34,704.35
Disclosure

SEC source: 0000313616-26-000012 · wk-form4_1770157550.xml · derivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,047.026

Underlying: Common Stock · 158.547 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
November 20, 2025 Filed Mar 5, 2026 23:20 UTC Structure Therapeutics Inc. GPCR · Entity 1222 GrantAmerican Depositary Shares · Derivative 824 $0.00 $0.00
Disclosure

SEC source: 0001698149-26-000002 · form4-03052026_060301.xml · derivative · entry 3

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,824

Underlying: Ordinary Shares · 2,472 shares

Expires not disclosed

F4 · derivative.exercise_price: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

F5 · kind: Voluntary reporting of the acquisition of 824 ADSs by the Reporting Person on November 20, 2025 pursuant to the Issuer's Employee Share Purchase Plan.

F4 · derivative.exercise_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

F4 · derivative.expiration_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
October 31, 2025 Filed Nov 3, 2025 22:01 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 160.891 $215.38 Strike: $0.00 $34,652.70
Disclosure

SEC source: 0000313616-25-000194 · wk-form4_1762207275.xml · derivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,888.48

Underlying: Common Stock · 160.891 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
July 25, 2025 Filed Jul 28, 2025 21:07 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 168.381 $205.48 Strike: $0.00 $34,598.93
Disclosure

SEC source: 0000313616-25-000168 · wk-form4_1753736813.xml · derivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,727.588

Underlying: Common Stock · 168.381 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
July 01, 2025 Filed Jul 3, 2025 21:15 UTC Structure Therapeutics Inc. GPCR · Entity 1222 Tax withholdingOrdinary Shares 16,050 $6.84 $109,727.43
Disclosure

SEC source: 0001415889-25-019350 · form4-07032025_050702.xml · nonDerivative · entry 3

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,194,830

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

F2 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.

Read SEC document
July 01, 2025 Filed Jul 3, 2025 21:15 UTC Structure Therapeutics Inc. GPCR · Entity 1222 GrantOrdinary Shares 89,697 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-019350 · form4-07032025_050702.xml · nonDerivative · entry 2

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,210,880

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

F3 · kind: On March 15, 2024, the reporting person was granted performance-vesting restricted share units ("PSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer, which vest upon satisfaction of certain performance criteria. Certain of the performance criteria was determined to have been met effective July 1, 2025. The shares subject to the PSUs vest as follows: 50% of the shares vested on July 1, 2025 and the remainder will vest on January 1, 2027 subject to the reporting person's Continuous Service (as defined in the Structure Therapeutics Inc. 2023 Equity Incentive Plan) through such vesting date.

Read SEC document
May 21, 2025 Filed Jul 3, 2025 21:15 UTC Structure Therapeutics Inc. GPCR · Entity 1222 GrantAmerican Depositary Shares · Derivative 1,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-019350 · form4-07032025_050702.xml · derivative · entry 5

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Ordinary Shares · 3,000 shares

Expires not disclosed

F5 · derivative.exercise_price: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

F6 · kind: Voluntary reporting of the acquisition of 1,000 ADSs by the Reporting Person on May 21, 2025 pursuant to the Issuer's Employee Share Purchase Plan.

F5 · derivative.exercise_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

F5 · derivative.expiration_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
May 15, 2025 Filed May 19, 2025 21:02 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantDirector stock option (right to buy) · Derivative 1,478 $0.00 Strike: $190.95 $0.00
Disclosure

SEC source: 0000313616-25-000136 · wk-form4_1747688532.xml · derivative · entry 2

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,478

Underlying: Common Stock · 1,478 shares

Expires 2035-05-15

Read SEC document
May 15, 2025 Filed May 19, 2025 21:02 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantCommon Stock 577 $0.00 $0.00
Disclosure

SEC source: 0000313616-25-000136 · wk-form4_1747688532.xml · nonDerivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,361.207

F1 · shares: On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board.

Read SEC document
April 25, 2025 Filed Apr 29, 2025 21:00 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 175.22 $197.14 Strike: $0.00 $34,542.87
Disclosure

SEC source: 0000313616-25-000101 · wk-form4_1745960444.xml · derivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,559.207

Underlying: Common Stock · 175.22 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
March 15, 2025 Filed Mar 19, 2025 00:45 UTC Structure Therapeutics Inc. GPCR · Entity 1222 GrantEmployee Stock Option (right to buy) · Derivative 826,890 $0.00 Strike: $7.02 $0.00
Disclosure

SEC source: 0001415889-25-008550 · form4-03182025_080301.xml · derivative · entry 3

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 826,890

Underlying: Ordinary Shares · 826,890 shares

Expires 2035-03-14

F4 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.

F5 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.

F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
March 15, 2025 Filed Mar 19, 2025 00:45 UTC Structure Therapeutics Inc. GPCR · Entity 1222 GrantOrdinary Shares 340,332 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-008550 · form4-03182025_080301.xml · nonDerivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,133,678

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

F2 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates.

Read SEC document
March 01, 2025 Filed Jul 3, 2025 21:15 UTC Structure Therapeutics Inc. GPCR · Entity 1222 Tax withholdingOrdinary Shares 12,495 $7.92 $98,917.92
Disclosure

SEC source: 0001415889-25-019350 · form4-07032025_050702.xml · nonDerivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,121,183

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

F2 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 22:36 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 147.858 $222.74 Strike: $0.00 $32,933.89
Disclosure

SEC source: 0000313616-25-000035 · wk-form4_1738708572.xml · derivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,383.987

Underlying: Common Stock · 147.858 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
October 25, 2024 Filed Oct 28, 2024 21:00 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 134.062 $245.39 Strike: $0.00 $32,897.47
Disclosure

SEC source: 0000313616-24-000234 · wk-form4_1730149241.xml · derivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,236.129

Underlying: Common Stock · 134.062 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
July 26, 2024 Filed Jul 29, 2024 21:01 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 119.985 $273.19 Strike: $0.00 $32,778.70
Disclosure

SEC source: 0000313616-24-000205 · wk-form4_1722286855.xml · derivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,102.067

Underlying: Common Stock · 119.985 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
June 12, 2024 Filed Jun 15, 2024 00:19 UTC Structure Therapeutics Inc. GPCR · Entity 1222 Exercise / conversionShare Option (right to buy) · Derivative 50,001 $0.00 Strike: $0.48 $0.00
Disclosure

SEC source: 0001415889-24-017040 · form4-06152024_120647.xml · derivative · entry 5

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 488,766

Underlying: Ordinary Shares · 50,001 shares

Expires 2031-01-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares vest in a series of 48 successive equal monthly installments beginning one month after January 22, 2021.

Read SEC document
June 12, 2024 Filed Jun 15, 2024 00:19 UTC Structure Therapeutics Inc. GPCR · Entity 1222 Exercise / conversionShare Option (right to buy) · Derivative 99,999 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001415889-24-017040 · form4-06152024_120647.xml · derivative · entry 4

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1

Underlying: Ordinary Shares · 99,999 shares

Expires 2030-01-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 12, 2024 Filed Jun 15, 2024 00:19 UTC Structure Therapeutics Inc. GPCR · Entity 1222 Exercise / conversionOrdinary Shares 50,001 $0.48 $24,000.48
Disclosure

SEC source: 0001415889-24-017040 · form4-06152024_120647.xml · nonDerivative · entry 2

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 793,346

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 12, 2024 Filed Jun 15, 2024 00:19 UTC Structure Therapeutics Inc. GPCR · Entity 1222 Exercise / conversionOrdinary Shares 99,999 $0.39 $38,999.61
Disclosure

SEC source: 0001415889-24-017040 · form4-06152024_120647.xml · nonDerivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 743,345

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 10, 2024 Filed Jun 12, 2024 20:42 UTC Structure Therapeutics Inc. GPCR · Entity 1222 SaleAmerican Depositary Shares · Derivative 185,000 $52.80 $9,767,352.50
Disclosure

SEC source: 0001415889-24-016510 · form4-06122024_080615.xml · derivative · entry 4

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 555,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

F4 · price: The weighted average sale price for the transaction was $52.7965, and the range of prices was $52.43 and $53.075. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

F3 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

F3 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

Read SEC document
June 10, 2024 Filed Jun 12, 2024 20:42 UTC Structure Therapeutics Inc. GPCR · Entity 1222 ConversionAmerican Depositary Shares · Derivative 185,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-016510 · form4-06122024_080615.xml · derivative · entry 3

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,000

Underlying: Ordinary Shares · 555,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

F3 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

F3 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

Read SEC document
June 10, 2024 Filed Jun 12, 2024 20:42 UTC Structure Therapeutics Inc. GPCR · Entity 1222 ConversionOrdinary Shares 555,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-016510 · form4-06122024_080615.xml · nonDerivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 643,346

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The Ordinary Shares were converted into American Depositary Shares as reported in Table II above.

Read SEC document
May 15, 2024 Filed May 17, 2024 21:10 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantDirector stock option (right to buy) · Derivative 1,081 $0.00 Strike: $263.46 $0.00
Disclosure

SEC source: 0000313616-24-000166 · wk-form4_1715980200.xml · derivative · entry 2

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,081

Underlying: Common Stock · 1,081 shares

Expires 2034-05-15

Read SEC document
May 15, 2024 Filed May 17, 2024 21:10 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantCommon Stock 390 $0.00 $0.00
Disclosure

SEC source: 0000313616-24-000166 · wk-form4_1715980200.xml · nonDerivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,207.082

F1 · shares: On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board.

Read SEC document
April 26, 2024 Filed Apr 29, 2024 21:00 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 133.139 $246.58 Strike: $0.00 $32,829.41
Disclosure

SEC source: 0000313616-24-000122 · wk-form4_1714424448.xml · derivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,982.082

Underlying: Common Stock · 133.139 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 20:36 UTC Structure Therapeutics Inc. GPCR · Entity 1222 GrantStock Option (right to buy) · Derivative 335,481 $0.00 Strike: $35.25 $0.00
Disclosure

SEC source: 0001415889-24-008561 · form4-03192024_080344.xml · derivative · entry 3

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 335,481

Underlying: Ordinary Shares · 335,481 shares

Expires 2034-03-14

F3 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 20:36 UTC Structure Therapeutics Inc. GPCR · Entity 1222 GrantOrdinary Shares 134,682 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-008561 · form4-03192024_080344.xml · nonDerivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,198,346

F1 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2024, subject to Reporting Person's continued service on such dates.

Read SEC document
March 15, 2024 Filed Mar 20, 2024 23:34 UTC Amendment Structure Therapeutics Inc. GPCR · Entity 1222 GrantStock Option (right to buy) · Derivative 335,481 $0.00 Strike: $11.75 $0.00
Disclosure

SEC source: 0001415889-24-008780 · form4a-03202024_110300.xml · derivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 335,481

Underlying: Ordinary Shares · 335,481 shares

Expires 2034-03-14

F1 · derivative.exercise_price: This amendment is being filed to correct the exercise price as that of the Ordinary Shares rather than the American Depositary Shares ("ADSs"). The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.

F2 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.

F3 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
January 26, 2024 Filed Jan 30, 2024 22:06 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 140.001 $233.00 Strike: $0.00 $32,620.23
Disclosure

SEC source: 0000313616-24-000022 · wk-form4_1706652373.xml · derivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,848.943

Underlying: Common Stock · 140.001 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
October 27, 2023 Filed Oct 30, 2023 21:02 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 174.283 $187.88 Strike: $0.00 $32,744.29
Disclosure

SEC source: 0000313616-23-000272 · wk-form4_1698699747.xml · derivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,708.941

Underlying: Common Stock · 174.283 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
July 28, 2023 Filed Aug 1, 2023 21:06 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 125.134 $260.07 Strike: $0.00 $32,543.60
Disclosure

SEC source: 0000313616-23-000242 · wk-form4_1690923966.xml · derivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,916.289

Underlying: Common Stock · 125.134 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
May 15, 2023 Filed May 17, 2023 21:05 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantDirector stock option (right to buy) · Derivative 1,194 $0.00 Strike: $226.94 $0.00
Disclosure

SEC source: 0000313616-23-000204 · wk-form4_1684357510.xml · derivative · entry 2

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,194

Underlying: Common Stock · 1,194 shares

Expires 2033-05-15

Read SEC document
May 15, 2023 Filed May 17, 2023 21:05 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantCommon Stock 430 $0.00 $0.00
Disclosure

SEC source: 0000313616-23-000204 · wk-form4_1684357510.xml · nonDerivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,083.155

F1 · shares: On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board.

Read SEC document
April 28, 2023 Filed May 1, 2023 21:06 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 137.211 $236.91 Strike: $0.00 $32,506.66
Disclosure

SEC source: 0000313616-23-000163 · wf-form4_168297519032863.xml · derivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,791.155

Underlying: Common Stock · 137.211 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
February 07, 2023 Filed Feb 9, 2023 23:58 UTC Structure Therapeutics Inc. GPCR · Entity 1222 PurchaseAmerican Depositary Shares · Derivative 4,000 $15.00 $60,000.00
Disclosure

SEC source: 0001209191-23-008159 · doc4.xml · derivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 4,000

Underlying: Ordinary Shares · 12,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

F2 · kind: The American Depositary Shares were purchased in the Issuer's initial public offering.

F1 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

F1 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

F3 · ownership.nature: By Raymond Stevens and Vivian Urena-Stevens, as Co-Trustees of the Stevens 2001 Revocable Trust, dated March 28, 2001.

Read SEC document
February 02, 2023 Filed Feb 6, 2023 21:45 UTC Structure Therapeutics Inc. GPCR · Entity 1222 GrantStock option (right to buy) · Derivative 1,600,000 $0.00 Strike: $15.00 $0.00
Disclosure

SEC source: 0001209191-23-007314 · doc4.xml · derivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,600,000

Underlying: Ordinary Shares · 1,600,000 shares

Expires 2033-02-01

F1 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on the first anniversary of February 2, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter.

Read SEC document
January 27, 2023 Filed Jan 30, 2023 22:08 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 121.75 $265.98 Strike: $0.00 $32,383.07
Disclosure

SEC source: 0000313616-23-000042 · wf-form4_167511647348898.xml · derivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,653.944

Underlying: Common Stock · 121.75 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
January 25, 2023 Filed Jan 26, 2023 22:06 UTC DANAHER CORP /DE/ DHR · Entity 2871 Exercise / conversionDirector stock option (right to buy) · Derivative 2,230 $0.00 Strike: $131.05 $0.00
Disclosure

SEC source: 0000313616-23-000008 · wf-form4_167477074086572.xml · derivative · entry 9

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,230 shares

Expires 2029-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 25, 2023 Filed Jan 26, 2023 22:06 UTC DANAHER CORP /DE/ DHR · Entity 2871 Exercise / conversionDirector stock option (right to buy) · Derivative 2,640 $0.00 Strike: $100.24 $0.00
Disclosure

SEC source: 0000313616-23-000008 · wf-form4_167477074086572.xml · derivative · entry 8

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,640 shares

Expires 2028-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 25, 2023 Filed Jan 26, 2023 22:06 UTC DANAHER CORP /DE/ DHR · Entity 2871 Exercise / conversionDirector stock option (right to buy) · Derivative 3,540 $0.00 Strike: $83.28 $0.00
Disclosure

SEC source: 0000313616-23-000008 · wf-form4_167477074086572.xml · derivative · entry 7

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,540 shares

Expires 2027-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 25, 2023 Filed Jan 26, 2023 22:06 UTC DANAHER CORP /DE/ DHR · Entity 2871 SaleCommon Stock 2,230 $264.24 $589,244.05
Disclosure

SEC source: 0000313616-23-000008 · wf-form4_167477074086572.xml · nonDerivative · entry 6

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,394.194

Read SEC document
January 25, 2023 Filed Jan 26, 2023 22:06 UTC DANAHER CORP /DE/ DHR · Entity 2871 Exercise / conversionCommon Stock 2,230 $131.05 $292,241.50
Disclosure

SEC source: 0000313616-23-000008 · wf-form4_167477074086572.xml · nonDerivative · entry 5

Stevens Raymond C · CIK 0001698149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,624.194

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.